These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3536078)

  • 21. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W; Zwanzger D; Borkhardt A
    Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cells.
    Brach MA; Riedel D; Mertelsmann RH; Herrmann F
    Leukemia; 1990 Sep; 4(9):646-9. PubMed ID: 2144331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
    Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
    J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
    Barnard JA; Warwick G
    Cell Growth Differ; 1993 Jun; 4(6):495-501. PubMed ID: 8373733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.
    Luisi-DeLuca C; Mitchell T; Spriggs D; Kufe DW
    J Clin Invest; 1984 Sep; 74(3):821-7. PubMed ID: 6590568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
    Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
    J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
    Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
    Sejersen T; Björklund H; Sümegi J; Ringertz NR
    J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion to the terminally differentiated state during treatment of NG108-15 neural tumor cells with 1-beta-D-arabinofuranosylcytosine in defined medium.
    Krystosek A
    Cancer Res; 1989 Jan; 49(2):450-8. PubMed ID: 2910463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
    Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
    Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T; Bravo R; Müller R
    Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.